These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33587508)

  • 1. Maternal HIV Infection and Spontaneous Versus Provider-Initiated Preterm Birth in an Urban Zambian Cohort.
    Price JT; Vwalika B; Edwards JK; Cole SR; Kasaro MP; Rittenhouse KJ; Kumwenda A; Lubeya MK; Stringer JSA
    J Acquir Immune Defic Syndr; 2021 Jun; 87(2):860-868. PubMed ID: 33587508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between HIV antiretroviral therapy and preterm birth based on antenatal ultrasound gestational age determination: a comparative analysis.
    Venkatesh KK; Farhad M; Fenton T; Moodley D; Naik S; Nakabiito C; Fairlie L; Fowler MG; Stringer JSA; Chi BH
    AIDS; 2019 Dec; 33(15):2403-2413. PubMed ID: 31764105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginal progesterone to prevent preterm delivery among HIV-infected pregnant women in Zambia: A feasibility study.
    Price JT; Phiri WM; Freeman BL; Vwalika B; Winston J; Mabula-Bwalya CM; Mulenga HB; Stringer JSA
    PLoS One; 2020; 15(1):e0224874. PubMed ID: 31995557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of diabetes, obesity and hypertension on preterm birth: Population-based study.
    Berger H; Melamed N; Davis BM; Hasan H; Mawjee K; Barrett J; McDonald SD; Geary M; Ray JG
    PLoS One; 2020; 15(3):e0228743. PubMed ID: 32210434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for preterm birth among HIV-infected pregnant Ugandan women randomized to lopinavir/ritonavir- or efavirenz-based antiretroviral therapy.
    Koss CA; Natureeba P; Plenty A; Luwedde F; Mwesigwa J; Ades V; Charlebois ED; Clark TD; Achan J; Ruel T; Nzarubara B; Kamya MR; Havlir DV; Cohan D
    J Acquir Immune Defic Syndr; 2014 Oct; 67(2):128-35. PubMed ID: 25072616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preterm birth and nativity among Black women with gestational diabetes in California, 2013-2017: a population-based retrospective cohort study.
    Scott KA; Chambers BD; Baer RJ; Ryckman KK; McLemore MR; Jelliffe-Pawlowski LL
    BMC Pregnancy Childbirth; 2020 Oct; 20(1):593. PubMed ID: 33023524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence risk of preterm births: a retrospective Indian study.
    Depa AR; Gundabattula SR
    J Obstet Gynaecol; 2020 Oct; 40(7):925-928. PubMed ID: 31791184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between HIV, antiretroviral therapy and preterm birth in the US Women's Interagency HIV Study, 1995-2018: a prospective cohort.
    Venkatesh KK; Edmonds A; Westreich D; Dionne-Odom J; Weiss DJ; Sheth AN; Cejtin H; Seidman D; Kassaye S; Minkoff H; Atrio J; Rahangdale L; Adimora AA
    HIV Med; 2022 Apr; 23(4):406-416. PubMed ID: 34514711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 infection during pregnancy and preterm birth in Massachusetts from March 2020 through March 2021.
    Darling AM; Shephard H; Nestoridi E; Manning SE; Yazdy MM
    Paediatr Perinat Epidemiol; 2023 Feb; 37(2):93-103. PubMed ID: 36512318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risks of preterm birth among non-Hispanic black and non-Hispanic white women: Effect modification by maternal age.
    Keiser AM; Salinas YD; DeWan AT; Hawley NL; Donohue PK; Strobino DM
    Paediatr Perinat Epidemiol; 2019 Sep; 33(5):346-356. PubMed ID: 31365156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preterm birth phenotypes in women with autoimmune rheumatic diseases: a population-based cohort study.
    Kolstad KD; Mayo JA; Chung L; Chaichian Y; Kelly VM; Druzin M; Stevenson DK; Shaw GM; Simard JF
    BJOG; 2020 Jan; 127(1):70-78. PubMed ID: 31571337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of big data for prediction of provider-initiated preterm birth and spontaneous premature deliveries and ranking the predictive features.
    Khatibi T; Kheyrikoochaksarayee N; Sepehri MM
    Arch Gynecol Obstet; 2019 Dec; 300(6):1565-1582. PubMed ID: 31650230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal genitourinary infections and poor nutritional status increase risk of preterm birth in Gasabo District, Rwanda: a prospective, longitudinal, cohort study.
    Nsereko E; Uwase A; Mukabutera A; Muvunyi CM; Rulisa S; Ntirushwa D; Moreland P; Corwin EJ; Santos N; Nzayirambaho M; Wojcicki JM
    BMC Pregnancy Childbirth; 2020 Jun; 20(1):345. PubMed ID: 32493304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revisiting the association between maternal and offspring preterm birth using a sibling design.
    Urquia ML; Wall-Wieler E; Ruth CA; Liu X; Roos LL
    BMC Pregnancy Childbirth; 2019 May; 19(1):157. PubMed ID: 31138142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for spontaneous and provider-initiated preterm delivery in high and low Human Development Index countries: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health.
    Morisaki N; Togoobaatar G; Vogel JP; Souza JP; Rowland Hogue CJ; Jayaratne K; Ota E; Mori R;
    BJOG; 2014 Mar; 121 Suppl 1():101-9. PubMed ID: 24641540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perinatal outcomes in women living with HIV-1 and receiving antiretroviral therapy-a systematic review and meta-analysis.
    Shinar S; Agrawal S; Ryu M; Walmsley S; Serghides L; Yudin MH; Murphy KE
    Acta Obstet Gynecol Scand; 2022 Feb; 101(2):168-182. PubMed ID: 34704251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preterm delivery risk in women initiating antiretroviral therapy to prevent HIV mother-to-child transmission.
    Short CE; Douglas M; Smith JH; Taylor GP
    HIV Med; 2014 Apr; 15(4):233-8. PubMed ID: 24025074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal and obstetric complications among HIV-infected women treated with highly active antiretroviral treatment at a Regional Hospital in Durban, South Africa.
    Sebitloane HM; Moodley J
    Niger J Clin Pract; 2017 Nov; 20(11):1360-1367. PubMed ID: 29303121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Birth outcomes in South African women receiving highly active antiretroviral therapy: a retrospective observational study.
    van der Merwe K; Hoffman R; Black V; Chersich M; Coovadia A; Rees H
    J Int AIDS Soc; 2011 Aug; 14():42. PubMed ID: 21843356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.